Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction. | Expert Opin Drug Discov;3(9): 1123-43, 2008 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Discovery of ABT-263, a Bcl-family protein inhibitor: observations on targeting a large protein-protein interaction.

Wendt, Michael D.

Affiliation

Wendt MD; Abbott Laboratories, Cancer Research, Global Pharmaceutical R&D, Dept R4N6, Bldg. AP10-3, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA +1 847 937 9305 ; +1 847 938 1004 ; mike.d.wendt@abbott.com.

Expert Opin Drug Discov ; 3(9): 1123-43, 2008 Sep.

Article in En | MEDLINE | ID: mdl-23506184

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Drug Discov Year: 2008 Document type: Article Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Expert Opin Drug Discov Year: 2008 Document type: Article Country of publication: United kingdom